CRES.BACRES.BABUE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+89.8%
5Y CAGR+53.0%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+89.8%/yr
Annual compound
5Y CAGR
+53.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
8.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$777.26B+111.1%
2025$368.12B+255.4%
2024$103.58B-8.9%
2023$113.72B+394.3%
2022$23.01B-75.2%
2021$92.86B-10.7%
2020$104.03B+291.7%
2019$-54.27B-634.8%
2018$10.15B-44.2%
2017$18.20B-